Literature DB >> 29409754

Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells.

Karthik Govindaraju1, Aude Ingels2, Md Nabiul Hasan3, Dandan Sun3, Veronique Mathieu2, Marco Masi4, Antonio Evidente4, Alexander Kornienko5.   

Abstract

In a search of small molecules active against apoptosis-resistant cancer cells, a skeletal rearrangement of alkaloid haemanthamine was utilized to generate a series of compounds possessing the alkaloid montanine ring system. The synthesized compounds were found to inhibit proliferation of cancer cells resistant to apoptosis at micromolar concentrations. Selected compounds were also active against patient-derived glioblastoma cells expressing stem-cell markers. This is the first report describing the preparation of synthetic analogues of the montanine-type alkaloids with antiproliferative activity. The compounds prepared in the current investigation appear to be a useful starting point for the development of agents to fight cancers with apoptosis resistance, and thus, associated with poor prognoses.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiproliferative activity; Apoptosis resistance; Haemanthamine; Manthine; Montanine

Mesh:

Substances:

Year:  2018        PMID: 29409754      PMCID: PMC5831727          DOI: 10.1016/j.bmcl.2018.01.041

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  30 in total

1.  Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis.

Authors:  Hermann Brenner
Journal:  Lancet       Date:  2002-10-12       Impact factor: 79.321

2.  Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas.

Authors:  Gwendoline Van Goietsenoven; Jenna Hutton; Jean-Paul Becker; Benjamin Lallemand; Francis Robert; Florence Lefranc; Christine Pirker; Guy Vandenbussche; Pierre Van Antwerpen; Antonio Evidente; Walter Berger; Martine Prévost; Jerry Pelletier; Robert Kiss; Terri Goss Kinzy; Alexander Kornienko; Véronique Mathieu
Journal:  FASEB J       Date:  2010-07-19       Impact factor: 5.191

Review 3.  Present and potential future issues in glioblastoma treatment.

Authors:  Florence Lefranc; Niloufar Sadeghi; Isabelle Camby; Thierry Metens; Olivier Dewitte; Robert Kiss
Journal:  Expert Rev Anticancer Ther       Date:  2006-05       Impact factor: 4.512

4.  Bulbispermine: a crinine-type Amaryllidaceae alkaloid exhibiting cytostatic activity toward apoptosis-resistant glioma cells.

Authors:  Giovanni Luchetti; Robert Johnston; Véronique Mathieu; Florence Lefranc; Kathryn Hayden; Anna Andolfi; Delphine Lamoral-Theys; Mary R Reisenauer; Cody Champion; Stephen C Pelly; Willem A L van Otterlo; Igor V Magedov; Robert Kiss; Antonio Evidente; Snezna Rogelj; Alexander Kornienko
Journal:  ChemMedChem       Date:  2012-03-02       Impact factor: 3.466

5.  The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells.

Authors:  Paul A Clark; Jordan T Gaal; Joslyn K Strebe; Cheri A Pasch; Dustin A Deming; John S Kuo; H Ian Robins
Journal:  J Clin Neurosci       Date:  2016-11-16       Impact factor: 1.961

6.  Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.

Authors:  Gwendoline Van Goietsenoven; Anna Andolfi; Benjamin Lallemand; Alessio Cimmino; Delphine Lamoral-Theys; Thierry Gras; Amina Abou-Donia; Jacques Dubois; Florence Lefranc; Véronique Mathieu; Alexander Kornienko; Robert Kiss; Antonio Evidente
Journal:  J Nat Prod       Date:  2010-07-23       Impact factor: 4.050

7.  Isolation of cancer stem cells from adult glioblastoma multiforme.

Authors:  Xiangpeng Yuan; James Curtin; Yizhi Xiong; Gentao Liu; Sebastian Waschsmann-Hogiu; Daniel L Farkas; Keith L Black; John S Yu
Journal:  Oncogene       Date:  2004-12-16       Impact factor: 9.867

8.  Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.

Authors:  Delphine Lamoral-Theys; Anna Andolfi; Gwendoline Van Goietsenoven; Alessio Cimmino; Benjamin Le Calvé; Nathalie Wauthoz; Véronique Mégalizzi; Thierry Gras; Céline Bruyère; Jacques Dubois; Véronique Mathieu; Alexander Kornienko; Robert Kiss; Antonio Evidente
Journal:  J Med Chem       Date:  2009-10-22       Impact factor: 7.446

Review 9.  Anoikis resistance and tumor metastasis.

Authors:  Craig D Simpson; Kika Anyiwe; Aaron D Schimmer
Journal:  Cancer Lett       Date:  2008-06-24       Impact factor: 8.679

10.  Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival.

Authors:  Michael Zorniak; Paul A Clark; Heather E Leeper; Matthew D Tipping; David M Francis; Kevin R Kozak; M Shahriar Salamat; John S Kuo
Journal:  Clin Cancer Res       Date:  2012-05-15       Impact factor: 12.531

View more
  7 in total

1.  Cytotoxicity and Antiviral Properties of Alkaloids Isolated from Pancratium maritimum.

Authors:  Marco Masi; Roberta Di Lecce; Natacha Mérindol; Marie-Pierre Girard; Lionel Berthoux; Isabel Desgagné-Penix; Viola Calabrò; Antonio Evidente
Journal:  Toxins (Basel)       Date:  2022-04-07       Impact factor: 5.075

Review 2.  Chemical and Biological Aspects of Montanine-Type Alkaloids Isolated from Plants of the Amaryllidaceae Family.

Authors:  Darja Koutová; Negar Maafi; Radim Havelek; Lubomír Opletal; Gerald Blunden; Martina Řezáčová; Lucie Cahlíková
Journal:  Molecules       Date:  2020-05-16       Impact factor: 4.411

3.  Semisynthetic Derivatives of Selected Amaryllidaceae Alkaloids as a New Class of Antimycobacterial Agents.

Authors:  Negar Maafi; Abdullah Al Mamun; Ondřej Janďourek; Jana Maříková; Kateřina Breiterová; Adéla Diepoltová; Klára Konečná; Anna Hošťálková; Daniela Hulcová; Jiří Kuneš; Eliška Kohelová; Darja Koutová; Marcela Šafratová; Lucie Nováková; Lucie Cahlíková
Journal:  Molecules       Date:  2021-10-04       Impact factor: 4.411

4.  Amaryllidaceae Alkaloids Decrease the Proliferation, Invasion, and Secretion of Clinically Relevant Cytokines by Cultured Human Colon Cancer Cells.

Authors:  Veronique Mathieu; Breana Laguera; Marco Masi; Sara Adriana Dulanto; Tanner W Bingham; Lucas W Hernandez; David Sarlah; Antonio Evidente; Denis L J Lafontaine; Alexander Kornienko; Michelle A Lane
Journal:  Biomolecules       Date:  2022-09-09

Review 5.  Structures and Biological Activities of Alkaloids Produced by Mushrooms, a Fungal Subgroup.

Authors:  Jesús G Zorrilla; Antonio Evidente
Journal:  Biomolecules       Date:  2022-07-24

6.  Amaryllidaceae Alkaloids of Different Structural Types from Narcissus L. cv. Professor Einstein and Their Cytotoxic Activity.

Authors:  Kateřina Breiterová; Darja Koutová; Jana Maříková; Radim Havelek; Jiří Kuneš; Martina Majorošová; Lubomír Opletal; Anna Hošťálková; Jaroslav Jenčo; Martina Řezáčová; Lucie Cahlíková
Journal:  Plants (Basel)       Date:  2020-01-22

7.  Alkaloids of Phaedranassa dubia (Kunth) J.F. Macbr. and Phaedranassa brevifolia Meerow (Amaryllidaceae) from Ecuador and its cholinesterase-inhibitory activity.

Authors:  Karen Acosta León; Alexandra Inca; Luciana R Tallini; Edison H Osorio; Jessica Robles; Jaume Bastida; Nora H Oleas
Journal:  S Afr J Bot       Date:  2020-09-18       Impact factor: 2.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.